Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Powles T, Huddart RA, Elliott T, Sarker SJ, et al. Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55.
PMID: 28034079

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016